HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

Shiga Toxins (Vero Toxin)

A class of toxins that inhibit protein synthesis by blocking the interaction of ribosomal RNA; (RNA, RIBOSOMAL) with PEPTIDE ELONGATION FACTORS. They include SHIGA TOXIN which is produced by SHIGELLA DYSENTERIAE and a variety of shiga-like toxins that are produced by pathologic strains of ESCHERICHIA COLI such as ESCHERICHIA COLI O157.
Also Known As:
Vero Toxin; Shiga-Like Toxins; Vero Cell Cytotoxin; Vero Cell Cytotoxins; Vero Cytotoxin; Vero Cytoxins; Verotoxin; Verotoxins; Cell Cytotoxins, Vero; Cytotoxin, Vero; Cytotoxin, Vero Cell; Cytotoxins, Vero Cell; Cytoxins, Vero; Shiga Like Toxins; Toxin, Vero; Toxins, Shiga; Toxins, Shiga-Like; Toxins, Vero; Vero Toxins
Networked: 365 relevant articles (3 outcomes, 19 trials/studies)

Relationship Network

Bio-Agent Context: Research Results

Experts

1. Brigotti, Maurizio: 5 articles (01/2015 - 09/2004)
2. Kurosawa, Shinichiro: 5 articles (01/2015 - 11/2012)
3. Carnicelli, Domenica: 5 articles (01/2015 - 09/2004)
4. Karch, Helge: 4 articles (12/2015 - 05/2002)
5. Thorpe, Cheleste M: 4 articles (01/2015 - 03/2003)
6. Stearns-Kurosawa, Deborah J: 4 articles (01/2015 - 11/2012)
7. Mayer, Chad L: 4 articles (01/2015 - 11/2012)
8. Binnington, Beth: 4 articles (11/2013 - 01/2010)
9. Lingwood, Clifford A: 4 articles (11/2013 - 06/2009)
10. Palermo, Marina S: 4 articles (09/2013 - 01/2011)

Related Diseases

1. Infection
2. Diarrhea
3. Acute Kidney Injury (Acute Renal Failure)
4. Hemolytic-Uremic Syndrome
5. Necrosis

Related Drugs and Biologics

1. Enterotoxins
2. colonization factor antigens
3. Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)
4. Sorbitol (Yal)
5. Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF)
6. Biological Markers (Surrogate Marker)
7. Epoprostenol (Prostacyclin)
8. Phosphotransferases (Kinase)
9. Shiga Toxins (Vero Toxin)
10. Virulence Factors (Pathogenicity Factors)

Related Therapies and Procedures

1. Transplants (Transplant)
2. Heterologous Transplantation (Xenotransplantation)
3. Immunomodulation
4. Immunotherapy
5. Day Care (Partial Hospitalization)